Comparative genomic analysis of multiple mammary tumors from a single dog: whole-genome sequencing study.

Gespeichert in:
Bibliographische Detailangaben
Titel: Comparative genomic analysis of multiple mammary tumors from a single dog: whole-genome sequencing study.
Autoren: Kim, Keon1 (AUTHOR), Shin, Tae-Hoon2 (AUTHOR), Park, Sin-Wook1 (AUTHOR), Park, Sang-Ik3 (AUTHOR), Do, Yoon Jung4 (AUTHOR), Ro, Woong-Bin1,5 (AUTHOR) woongbinro@jnu.ac.kr, Lee, Chang-Min1,5 (AUTHOR) cmlee1122@jnu.ac.kr
Quelle: Irish Veterinary Journal. 10/30/2025, Vol. 78 Issue 1, p1-16. 16p.
Publikationsart: Case Study
Schlagworte: Mammary gland cancer, Whole genome sequencing, Dog genetics, Somatic mutation, Clone cells, Genetic variation, Comparative genomics, Benign tumors
Author-Supplied Keywords: Breast cancer
Canine
Mammary gland tumor
Medical and Health Sciences Oncology and Carcinogenesis Biological Sciences Genetics
Next-generation sequencing
Whole-genome sequencing
Abstract: Background: Next-generation sequencing of canine spontaneous cancer is a powerful approach in both comparative oncology and veterinary genomics. We encountered a unique case with concurrent mammary tumors. Using whole-genome sequencing (WGS), we profiled the tumor-specific landscape of somatic mutations across multiple tumor subtypes, providing unprecedented evidence within an identical genetic background. Results: Of the seven mammary gland tumors (MGTs) isolated, two were diagnosed as benign and five as malignant. High-quality WGS (34.5X average sequencing depth, ≥ 20X coverage across 94.9% of the genome) on tumors and a blood sample revealed missense mutations in human breast cancer-related genes such as BRCA2 and TP53. Furthermore, we found evidence of canine-specific somatic mutations depending on the tumor subtypes, including HECTD4 in malignant tumors and NIPBL in epithelial-derived malignant tumors. Conclusions: This unique case study provides novel insights into the genomic heterogeneity, clonal evolution, and subtype-specific pathogenesis of naturally occurring canine MGTs. Despite some inherent limitations and potential for individual-specific variation, our results emphasize and guide future large-scale, longitudinal studies to further elucidate the clinical and biological significance of key somatic alterations. [ABSTRACT FROM AUTHOR]
Copyright of Irish Veterinary Journal is the property of BioMed Central and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Author Affiliations: 1https://ror.org/05kzjxq56 Department of Veterinary Internal Medicine, College of Veterinary Medicine and BK21 FOUR program, Chonnam National University, 61186, Gwangju, Republic of Korea
2https://ror.org/05hnb4n85 Department of Laboratory Animal Medicine, College of Veterinary Medicine, Veterinary Medical Research Institute, Jeju National University, 63243, Jeju, Republic of Korea
3https://ror.org/05kzjxq56 Department of Veterinary Pathology, College of Veterinary Medicine, Chonnam National University, 61186, Gwangju, Republic of Korea
4https://ror.org/02ty3a980 Division of Animal Diseases & Health, Rural Development Administration, National Institute of Animal Science, 55365, Wanju-gun, Republic of Korea
577 Yongbongro buk-gu, Gwangju, Republic of Korea
Full Text Word Count: 10481
ISSN: 0368-0762
DOI: 10.1186/s13620-025-00311-5
Dokumentencode: 189002670
Datenbank: Veterinary Source
Volltext ist per Gastzugang nicht verfügbar.
Beschreibung
Abstract:Background: Next-generation sequencing of canine spontaneous cancer is a powerful approach in both comparative oncology and veterinary genomics. We encountered a unique case with concurrent mammary tumors. Using whole-genome sequencing (WGS), we profiled the tumor-specific landscape of somatic mutations across multiple tumor subtypes, providing unprecedented evidence within an identical genetic background. Results: Of the seven mammary gland tumors (MGTs) isolated, two were diagnosed as benign and five as malignant. High-quality WGS (34.5X average sequencing depth, ≥ 20X coverage across 94.9% of the genome) on tumors and a blood sample revealed missense mutations in human breast cancer-related genes such as BRCA2 and TP53. Furthermore, we found evidence of canine-specific somatic mutations depending on the tumor subtypes, including HECTD4 in malignant tumors and NIPBL in epithelial-derived malignant tumors. Conclusions: This unique case study provides novel insights into the genomic heterogeneity, clonal evolution, and subtype-specific pathogenesis of naturally occurring canine MGTs. Despite some inherent limitations and potential for individual-specific variation, our results emphasize and guide future large-scale, longitudinal studies to further elucidate the clinical and biological significance of key somatic alterations. [ABSTRACT FROM AUTHOR]
ISSN:03680762
DOI:10.1186/s13620-025-00311-5